Atria Wealth Solutions, Inc. Eli Lilly & CO Transaction History

Atria Wealth Solutions, Inc.

$8.89 Billion
Q3 2024

A detailed history of Atria Wealth Solutions, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 42,508 shares of LLY stock, worth $33.1 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

42,508

Previous 43,365 1.98%

Holding current value

$33.1 Million

Previous $39.3 Million 4.08%

% of portfolio

0.42%

Previous 0.45%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $661,723 - $822,737	-857 Reduced 1.98%	42,508 $37.7 Million
Q2 2024 Jul 22, 2024	BUY	$724.87 - $909.04 $45,666 - $57,269	63 Added 0.15%	43,365 $39.3 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $586,870 - $785,149	-991 Reduced 2.24%	43,302 $33.7 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $1.14 Million - $1.34 Million	2,171 Added 5.15%	44,293 $25.8 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $1.5 Million - $2.07 Million	3,452 Added 8.93%	42,122 $22.6 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $2.07 Million - $2.76 Million	5,891 Added 17.97%	38,670 $18.1 Million
Q1 2023 Aug 22, 2023	SELL	$310.63 - $364.82 $1.31 Million - $1.53 Million	-4,204 Reduced 10.87%	34,466 $11.8 Million
Q1 2023 Jun 14, 2023	SELL	$310.63 - $364.82 $524,032 - $615,451	-1,687 Reduced 4.89%	32,779 $11.3 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $274,596 - $322,500	884 Added 2.63%	34,466 $11.8 Million
Q4 2022 Aug 30, 2023	SELL	$321.55 - $374.67 $1.89 Million - $2.21 Million	-5,891 Reduced 15.23%	32,779 $12 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $440,201 - $512,923	1,369 Added 4.25%	33,582 $12.3 Million
Q3 2022 Feb 13, 2023	SELL	$296.48 - $337.87 $657,296 - $749,057	-2,217 Reduced 6.44%	32,213 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $3.08 Million - $3.51 Million	10,399 Added 43.27%	34,430 $11.1 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.44 Million - $1.69 Million	-5,160 Reduced 17.68%	24,031 $7.79 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $6.85 Million - $8.51 Million	29,191 New	29,191 $8.36 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Account

Atria Wealth Solutions, Inc. Eli Lilly & CO Transaction History